<DOC>
	<DOCNO>NCT00248560</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , gemcitabine docetaxel , work different way stop growth tumor cell , either kill cell stop divide . Giving one drug ( combination chemotherapy ) may kill tumor cell . PURPOSE : This phase II trial study well give gemcitabine together docetaxel work treat patient persistent , recurrent , metastatic head neck cancer .</brief_summary>
	<brief_title>Gemcitabine Docetaxel Treating Patients With Persistent , Recurrent , Metastatic Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine response rate patient previously treat persistent , recurrent , metastatic squamous cell carcinoma head neck treat gemcitabine docetaxel . Secondary - Determine toxicity regimen patient . - Determine duration response survival patient treat regimen . OUTLINE : Patients receive gemcitabine IV 30 minute docetaxel IV 60 minute day 1 . Courses repeat every 14 day absence disease progression unacceptable toxicity . Patients achieve complete response ( CR ) receive 4 additional course therapy beyond documentation CR . After completion study treatment , patient follow survival . PROJECTED ACCRUAL : A total 17-41 patient accrue within 42-49 month .</detailed_description>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm squamous cell carcinoma head neck Metastatic , persistent , recurrent disease Measurable disease , define ≥ 1 unidimensionally measurable lesion ≥ 20 mm conventional technique OR ≥ 10 mm spiral CT scan Must definitive surgery and/or radiation therapy AND receive least 1 , 2 , chemotherapy regimen , either give primary therapy adjuvant therapy surgery and/or radiotherapy No active prior CNS metastasis PATIENT CHARACTERISTICS : Age 18 Performance status SWOG 02 Life expectancy At least 12 week Hematopoietic Granulocyte count &gt; 1,500/mm^3 Hemoglobin ≥ 8 g/dL Platelet count &gt; 100,000/mm^3 Hepatic Bilirubin normal Meets 1 follow criterion : Alkaline phosphatase ( AP ) normal AND AST ALT ≤ 5 time upper limit normal ( ULN ) AP ≤ 2.5 time ULN AND AST ALT ≤ 1.5 time ULN AP ≤ 5 time ULN AND AST ALT normal Renal Creatinine &lt; 1.5 mg/dL Other Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception ≥ 3 month completion study treatment No peripheral neuropathy ≥ grade 2 No active infection require systemic therapy No malignancy within past 5 year except adequately treat basal cell squamous cell skin cancer carcinoma situ cervix site No history severe hypersensitivity reaction study drug drug formulate polysorbate 80 No serious condition would preclude study treatment PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy See Disease Characteristics No prior taxane gemcitabine At least 4 week since prior chemotherapy recover Endocrine therapy Not specify Radiotherapy See Disease Characteristics At least 4 week since prior radiotherapy recover Surgery See Disease Characteristics Other No concurrent therapy disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>metastatic squamous neck cancer occult primary squamous cell carcinoma</keyword>
	<keyword>recurrent metastatic squamous neck cancer occult primary</keyword>
	<keyword>recurrent squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV squamous cell carcinoma paranasal sinus nasal cavity</keyword>
</DOC>